Coherus Biosciences(CHRS)
$0.58-0.06 (-9.06%)
CHRS
Coherus Biosciences Revenue
$0.58
At close:-0.06 (-9.06%)
Want to see CHRS full AI Analyst Report?
Coherus Biosciences (CHRS) Revenue
1,705 Followers
Coherus Biosciences Revenue
Coherus Biosciences had a revenue of 14.27M in the quarter ending Sep 30, 2026, with -0.23%. This bring the company's revenue in the last twelve months to 53.64M, Increased 5.31%. In the fiscal year ending Dec 31, 2025, Coherus Biosciences had annual revenue of 42.17M with -84.20% growth.
- Revenue (ttm)
- 53.64M
- Revenue Growth
- -35.81%
- P/S Ratio
- 2.35
- Revenue/Employee
- $290,841
- Employees
- 145
- Market Cap
- $99.04M
Revenue Chart
Coherus Biosciences Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.17M | -224.79M | -84.20% |
| Dec 31, 2024 | 266.96M | 9.72M | 3.78% |
| Dec 31, 2023 | 257.24M | 46.20M | 21.89% |
| Dec 31, 2022 | 211.04M | -115.51M | -35.37% |
| Dec 31, 2021 | 326.55M | -149.27M | -31.37% |
| Dec 31, 2020 | 475.82M | 119.75M | 33.63% |
| Dec 31, 2019 | 356.07M | 354.51M | 22783.74% |
| Dec 31, 2018 | 1.56M | 0.00 | 0.00% |
| Dec 31, 2017 | 1.56M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.